MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
Long-read genome sequencing is being integrated early into ASO therapy development to capture complex genetic variants missed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results